Hydrogen and health / Research review
Molecular hydrogen and COPD: what the studies show
COPD is an area in which inhalation of a hydrogen-oxygen mixture has been tested in a multicentre double-blind trial. After 7 days, exacerbation symptoms had decreased more than twice as much as with oxygen alone.
Covers
Studies
Human studies: 5 studies in the cards below, including 1 randomised.
How hydrogen was given
Inhalation, hydrogen water.
On this page
COPD: key findings from the studies
- A trial at 10 centres: the score on the breathlessness, cough and sputum scale fell by 5.3 points, against 2.4 points with oxygen alone.
- Adverse events were reported less often than in the oxygen group: 63% versus 78%.
- A hydrogen-oxygen mixture has a low density, so it flows more easily through narrowed airways.
Hydrogen and COPD: why researchers are testing inhalation
In COPD the airways are chronically exposed to oxidative stress and inflammation, mainly because of tobacco smoke. In people with asthma and COPD, the authors observed a lower level of the inflammatory protein MCP-1 in the airways after a single inhalation1. The second reason is purely physical: a hydrogen-oxygen mixture has a low density, so it flows more easily through narrowed airways. In 35 people with severe narrowing of the trachea, the authors observed less diaphragm effort when breathing such a mixture2.
Hydrogen inhalation in a COPD exacerbation: the largest trial
In the 2021 trial by Zheng et al., 108 people hospitalised with an exacerbation of COPD received for 7 days either a hydrogen-oxygen mixture in a 2:1 ratio or oxygen alone, always in addition to standard treatment3. The score on the Breathlessness, Cough and Sputum Scale (BCSS) fell by 5.3 points in the hydrogen group and by 2.4 points in the oxygen group. The CAT questionnaire score improved by 11 versus 6 points.
Adverse events were reported by 63% of people in the hydrogen-oxygen group and 78% in the oxygen group.
Stable COPD and asthma: hydrogen pilot studies
In a pilot study of 6 people with stable COPD, after 30 days of inhalation the median score on the CAT symptom questionnaire fell from 15.5 to 8.5 points, and on the mMRC breathlessness scale from 2.5 to 2.04. After a single 45-minute inhalation in 10 people with COPD and 10 with asthma, the authors observed lower levels of selected markers of inflammation in exhaled air, without a placebo group1. In a 10-person pilot study, hydrogen water combined with training was associated with a rise in oxygen saturation5.
Hydrogen and COPD: the studies we refer to
Click an entry to see who took part in the study, how hydrogen was given and what the result was.
What the studies say
Selected scientific publications on molecular hydrogen in humans: a description of each study, its results and a link to the source.
1Inflammatory markers of the airways in asthma and COPD
no control groupn = 20inhalation2020
Inflammatory markers of the airways in asthma and COPD
- Participants
- 10 people with asthma and 10 with COPD
- Protocol
- A single 45 min session of a mixture containing 2.4% H2
- Result
- MCP-1 fell in COPD from 564.7 to 451.5 pg/ml and in asthma from 386.4 to 332.8 pg/ml. Selected cytokines in exhaled breath condensate were lower.
- Study context
- Prospective before–after study without placebo. Participants: 20.
Wang ST i wsp.. Hydrogen gas (XEN) inhalation ameliorates airway inflammation in asthma and COPD patients. QJM : monthly journal of the Association of Physicians 113(12): 870-875. 2020. PubMed 32407476 · DOI · Full text
2Severe tracheal stenosis
controlled studyn = 35inhalation2018
Severe tracheal stenosis
- Participants
- In sequence: air, H2/O2, oxygen and H2/O2 again
- Protocol
- H2/O2 2:1, 6 l/min; short periods and a 120-minute exposure
- Result
- Diaphragm activity (EMGdi) fell from about 53% to 42.5% during H2/O2; diaphragmatic pressure decreased by an average of 4.77 cm H2O. The Borg score was also better.
- Study context
- Prospective self-controlled study, fixed order of gases. Participants: 35.
Zhou ZQ i wsp.. Breathing Hydrogen-Oxygen Mixture Decreases Inspiratory Effort in Patients with Tracheal Stenosis. Respiration; international review of thoracic diseases 97(1): 42-51. 2018. PubMed 30227423 · DOI
3Exacerbation of COPD
randomised trialn = 107inhalation2021
Exacerbation of COPD
- Participants
- 108 randomised; 107 in the full analysis set
- Protocol
- H2/O2 2:1 vs oxygen for 7 days, alongside standard treatment
- Result
- BCSS fell by 5.3 vs 2.4 points; adjusted difference −2.75 points (95% CI −3.27 to −2.22). CAT score: −11 vs −6 points (p<0.001).
- Study context
- RCT, 10 centres, double-blind. Participants: 107.
Zheng ZG i wsp.. Hydrogen/oxygen therapy for the treatment of an acute exacerbation of chronic obstructive pulmonary disease: results of a multicenter, randomized, double-blind, parallel-group controlled trial. Respiratory research 22(1): 149. 2021. PubMed 33985501 · DOI · Full text
4Symptoms of stable COPD, a pilot study
no control groupn = 6inhalation2024
Symptoms of stable COPD, a pilot study
- Participants
- People with COPD on standard treatment
- Protocol
- 30 min in the morning, afternoon and evening for 30 days
- Result
- Median CAT fell from 15.5 to 8.5 (p=0.043), mMRC from 2.5 to 2.0 (p=0.046).
- Study context
- Open-label before–after study without a control. Participants: 6.
Liu SF i wsp.. The Benefit of Hydrogen Gas as an Adjunctive Therapy for Chronic Obstructive Pulmonary Disease. Medicina (Kaunas, Lithuania) 60(2): 245. 2024. PubMed 38399533 · DOI · Full text
5Oxygen saturation in chronic lung diseases
Hydrogen waterno control groupn = 102023
Oxygen saturation in chronic lung diseases
- Participants
- 7 COPD, 2 asthma, 1 tuberculosis; baseline SpO2 90–95%
- Protocol
- High-concentration H2 water from tablets for 4 weeks
- Result
- A rise in SpO2 and a fall in indices of lipid peroxidation from baseline were described.
- Study context
- Before–after pilot study without a control. Participants: 10.
Singh RB i wsp.. Can Hydrogen Water Enhance Oxygen Saturation in Patients with Chronic Lung Disease? A Non-Randomized, Observational Pilot Study. Diseases (Basel, Switzerland) 11(4): 127. 2023. PubMed 37873771 · DOI · Full text
Educational information, not medical advice. Full database of publications: Hydrogen Studies.
COPD: topics in this area
COPD and hydrogen: frequently asked questions
How was hydrogen given in the COPD studies?
In the largest trial, participants breathed a hydrogen-oxygen mixture in a 2:1 ratio for 7 days, alongside standard hospital care. In the pilot study in stable COPD, inhalation lasted 30 minutes three times a day for 30 days, and the study of inflammation markers used a single 45-minute session.
Was hydrogen inhalation well tolerated in COPD?
In the multicentre trial, adverse events were reported by 63% of people in the hydrogen-oxygen group and 78% in the oxygen-only group.
Is it a medical device?
No. PRAGMA HYDROGEN is a device for wellness use. It does not replace a consultation with a doctor.
Is hydrogen inhalation safe?
In clinical trials, hydrogen inhalation was well tolerated. The generator has 8 safety features that stop it working if a fault occurs. Hydrogen is a flammable gas: do not smoke or use an open flame near the device. People with chronic conditions, pregnant women and children should consult a doctor before use.